A single arm, open-label, multicenter study evaluating the long-term safety and tolerability of 0.5 mg fingolimod (FTY720) administered orally once daily in patients with relapsing forms of multiple sclerosis

Chercheur principal: 

Jean-Pierre Bouchard

Organisme subventionnaire: 

Novartis Canada Ltd

Statut: 
Projet en cours

CIUSSS-CN Université Laval Alliance santé Québec